When the New Year rolls around, Maryland hospitals will charge the same prices for the care they deliver as they did at the end of 2013, a state commission decided Wednesday.
Tagged with: Affordable Care Act maryland medicine obamacare
Read More »December 4, 2013 Comments Off on Hospital rates unchanged for early ’14
When the New Year rolls around, Maryland hospitals will charge the same prices for the care they deliver as they did at the end of 2013, a state commission decided Wednesday.
Tagged with: Affordable Care Act maryland medicine obamacare
Read More »November 25, 2013 Comments Off on FDA: Avandia not risky medication
WASHINGTON — The Food and Drug Administration is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart attack. The repeal means patients will ...
Tagged with: FDA food and drug administration medication medicine
Read More »November 3, 2013 Comments Off on New Md. company Nutroganics dreams of healthy growth
Nutroganics, a new Maryland company in health products, is working through a sequence of corporate calisthenics in pursuit of rapid growth.
Tagged with: breaking news Business food maryland medicine organic
Read More »October 20, 2013 Comments Off on Hospitals test new care-delivery and payment models
As regulators await word from federal health officials about the state’s proposal to transform its hospital payment system to emphasize quality of care over quantity of services, some physicians and hospital executives aren’t waiting around.
Tagged with: breaking news hospitals maryland medicine rates
Read More »September 30, 2013 Comments Off on Baltimore biotech Gliknik, Pfizer sign accord
Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.
Tagged with: Baltimore biotechnology Business company maryland medicine pfizer pharmaceutical
Read More »September 25, 2013 Comments Off on UMB, MedImmune agree to collaborate
The University of Maryland, Baltimore and MedImmune Inc., of Gaithersburg, a subsidiary of British drug maker AstraZeneca PLC, announced they have entered into a five-year, $6 million agreement to work on novel bioscience research in Maryland.
Tagged with: Baltimore breaking news collaboration medicine medimmune merger science University of Maryland
Read More »September 17, 2013 Comments Off on KinderMender uses IT, child-centric focus to differentiate itself, expand
Dr. Keyvon Rafei doesn’t like being taken by surprise. He doesn’t appreciate unexpected surges in patient volume. He doesn’t enjoy paying employees top dollar to monitor empty waiting rooms. He hates guessing which illnesses will plague his patients, which neighborhoods they live in or what they thought about their visit to KinderMender, the pediatric urgent care clinic he founded.
Tagged with: Columbia data IT maryland medicine Technology
Read More »September 13, 2013 Comments Off on House unveils bill to police specialty pharmacies
WASHINGTON — House lawmakers have introduced legislation that would bring more federal oversight to large specialty pharmacies like the one that triggered a deadly meningitis outbreak last year. The bill introduced late Thursday by Republicans and Democrats would subject large ...
Tagged with: breaking news Business food and drug administration medicine senate washington
Read More »September 11, 2013 Comments Off on EAGB receives federal grant for biotech growth
A sizeable portion of a federal grant will go toward launching an intensive, 16-week accelerator program for health information technology entrepreneurs in Maryland.
Tagged with: biotech Economic Alliance of Greater Baltimore Government medicine rep. dutch ruppersberger Technology
Read More »September 4, 2013 Comments Off on Early look at health law’s premiums
WASHINGTON — It’s the No. 1 question about President Barack Obama’s health care law: Will consumers be able to afford the coverage? Now the answer is coming in. The biggest study yet of premiums posted by states finds that the ...
Tagged with: Barack Obama health insurance Insurance medicine obamacare overhaul united states
Read More »